Ironwood Pharmaceuticals reported $39.68M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 102.18M 13.03M
AstraZeneca AZN:LN 12.3B 763M
Bluebird Bio BLUE:US $ 137.27M 102.36M
Ironwood Pharmaceuticals IRWD:US $ 39.68M 20.86M
Lexicon Pharmaceuticals LXRX:US 23.42M 1.93M
Myriad Genetics MYGN:US $ 203.9M 78.5M